Skip to main content

Table 1 General inclusion and exclusion criteria

From: Intravenous immunoglobulin in the treatment of primary trigeminal neuralgia refractory to carbamazepine: a study protocol[ISRCTN33042138]

Inclusion criteria
Primary idiopathic trigeminal neuralgia
Age over 18
Insufficient benefit from carbamazepine therapy
Exclusion criteria
Serum IgA less than half normal value
Pregnancy or breastfeeding mothers
Progressive renal failure
Bedridden patients
Any disorder requiring treatment with IVIG